The present invention generally relates to active implantable medical devices and hermetic terminal subassemblies. More particularly, the present invention relates to a hermetic terminal for an active implantable medical device having an anisotropic conductive layer electrically connecting the hermetic feedthrough to a feedthrough filter capacitor disposed on the device side.
As used herein, the term “lead” refers to an implantable lead containing a lead body and one or more internal lead conductors. A “lead conductor” refers to the conductor that is inside of an implanted lead body. The term “leadwire” or “lead wire” refers to wiring that is either inside of the active implantable medical device (AIMD) housing or inside of the AIMD header block assembly or both. Furthermore, as used herein, in general, the terms lead, leadwire and pin are all used interchangeably. Importantly, they are all electrical conductors. This is why, in the broad sense of the term, lead, leadwire or pin can all be used interchangeably since they are all conductors. The term “conductive pathway” can also be used to be synonymous with lead conductor, lead, leadwire or pin or even a circuit trace. As described herein, composite conductive sintered paste filled vias passing through an insulator in nonconductive relation with a ferrule electrically acts the same as leadwire, lead wire, or pin. These sintered-paste filled vias may also incorporate co-fired solid leadwires. As used herein, the term paste generally refers to pastes, inks, gels, paints, cermets, and other such metal and/or metal/ceramic sinterable material combinations that can be flowable, injectable, pressed, pulled, pushed or otherwise movable into an orifice or via. Post-sintering, the solvents and binders are baked out and, after sintering, the paste becomes a densified solid with monolithic structure. Additionally, AIMD, as defined herein, includes electronic circuits disposed within the human body that have a primary or secondary battery, or have an alternative energy source, such as energy induced by motion, thermal or chemical effects or through external induction. As used herein, the term “header block” is the biocompatible material that attaches between the AIMD housing and the lead. The term “header block connector assembly” refers to the header block including the connector ports for the leads and the wiring connecting the lead connector ports to the hermetic terminal subassemblies which allow electrical connections to hermetically pass inside the device housing. It is also understood by those skilled in the art that the present invention can be applicable to active implantable medical devices that do not have a header block or header block connector assemblies such as pulse generators.
As defined herein, what is referred to as the insulator is generally disposed between or inside a ferrule opening and has either lead conductors or conductive passageways or vias that pass through the hermetic terminal subassembly 120. The ceramic capacitor 130 also uses insulative materials, which are dielectrics. As previously described in
Referring once again to
Referring once again to
The feedthrough capacitors 132, when properly installed, acts electrically as a continuous part of the titanium shield 116, which houses the active implantable medical device (AIMD). The feedthrough capacitor is a 3-terminal coaxial device whose internal electrode plates “plug the hole” and both reflect and absorb EMI fields. The feedthrough capacitor is novel in that, it is a broadband low pass filter, which allows desirable frequencies (like pacing pulses) to pass. Because it is a unique 3-terminal coaxial device, it provides effective attenuation to undesired signals (EMI) over a very broad band (10 MHz to 10 GHz frequency range). When designed and installed properly, feedthrough capacitors are very low inductance devices, which do not series resonate. It is very important that feedthrough capacitors be installed in such a way that undesirable resistances, for example, due to titanium oxides, cannot occur in the ground connection.
Referring once again to
Referring once again to
Referring once again to
Active implantable medical devices, in general, have a hermetically sealed feedthrough. This is necessary because, in general, the AIMDs have a completely enclosed and usually metallic housing. Leadwires that stimulate body tissue must pass through the conductive housing in nonconductive relationship so that they do not short out. This is where the hermetic seal is important, such that body fluids cannot enter into the conductive housing and damage sensitive electronic circuits. Damage can happen due to corrosion, formation of dendrites, or the like. Over the last years, feedthroughs for AIMDs have been increasing channel counts. What this means is, for example, with cardiac pacemakers, these use to be unipolar, single wired devices that paced only the right ventricle. Modern pacemakers, such as CRT-P pacemakers may have 12 or more leads. Even more dramatically, in the neurostimulator field, spinal cord stimulators have evolved from 8 channels to 32 channels and even more. For retinal stimulators, initial devices only had 8 channels (8 pixels) to create an image for a blind person. However, prototypes and devices on the drawing board, now have hundreds, if not thousands of channels. In the past, when the channel count was low, electrical connections were relatively easy to make and could be done by using discrete connections, such as BGA dots, solder connections or syringe-dispensed conductive adhesives. However, when channel counts get very high and channels are very close together, such former connection concepts become unworkable. Accordingly, there is a need for making an electrical connection for active implantable medical devices where the pitch (the spacing between adjacent conductors) is small and the channel count (the number of feedthrough conductors) is very high. There is another trend and that is the elimination of feedthrough wires through the hermetically sealed feedthroughs for AIMDs. The reason for this is that feedthrough wires are generally installed in alumina type insulators and are gold brazed to form both a mechanical and a hermetic seal. The problem with these prior art techniques, even though they were very successful and very biocompatible, is that they use up a lot of space. In other words, they are large in diameter. When the channel counts are very, very high, it is simply not possible to have a leadwire, an associated gold braze and the sputter layers. Increasingly, using sintered vias, instead of those with a gold braze leadwire, are becoming more popular. These co-sintered vias, for example, as described by U.S. Patent Application Pub. No. 2018/0197661, the contents of which are incorporated herein fully by reference. By definition, hermetic seals for AIMDs pass from a body fluid side to a device side. The body fluid side is the device oriented towards the leadwires, which pass through body tissues and either deliver therapy pulses or sense biological signals. On the device side, the hermetic seal conductive pathway is connected to AIMD internal circuitry, including power sources. The present invention will address novel uses of anisotropic conductive layers to make connections to hermetic seals for active implantable medical devices, both on the device side and on the body fluid side. For the body fluid side application, as will be described, the anisotropic conductive layers must be biocompatible, non-toxic and biostable.
An exemplary embodiment of the present invention is a filter feedthrough (210) for an active implantable medical device (AIMD, 100). An electrically conductive ferrule (112) is configured to hermetically seal an opening (115) of a housing (116) of the AIMD (100). The ferrule is configured to separate a body fluid side opposite a device side. The ferrule includes a ferrule opening (113) extending between and to the body fluid side and the device side. When the ferrule is attached to the opening of the housing of the AIMD, the body fluid side resides outside the AIMD housing and device side resides inside the AIMD housing. An insulator (160) hermetically seals the ferrule opening. The insulator is configured to separate the body fluid side and the device side. A first conductive pathway (114, 117, 185, 186, 186W) is hermetically sealed to and disposed through the insulator between the body fluid side and the device side, the first conductive pathway being in non-electrically conductive relation with the ferrule. A feedthrough capacitor (132) is disposed on the device side, the feedthrough capacitor comprises: at least one active electrode plate (148) disposed parallel and spaced from at least one ground electrode plate (146), wherein the at least one active and ground electrode plates are disposed within a capacitor dielectric (147,149); a capacitor active metallization (144) electrically connected to the at least one active electrode plate and in non-electrically conductive relation with the at least one ground electrode plate; and a capacitor ground metallization (142) electrically connected to the at least one ground electrode plate and in non-electrically conductive relation with the at least one active electrode plate. An anisotropic conductive layer (212′) is disposed on the device side, where the anisotropic conductive layer is electrically connecting the capacitor active metallization to the first conductive pathway.
In other variations of the exemplary embodiment, the anisotropic conductive layer (212′) may comprise a plurality of electrically conductive particles (262, 262′) disposed within an electrically insulative matrix (213).
The anisotropic conductive layer may comprise at least one conductive location, wherein the at least one conductive location may comprise at least one electrically connected particle (262′) of the plurality of electrically conductive particles, the at least one electrically connected particle physically abutted on both a first end (263a) opposite a second end (263b), wherein the first end may be electrically connected to the capacitor active metallization and the second end may be electrically connected to the first conductive pathway. In at least another embodiment, the ACL includes the at least one electrically conductive particle and the conductive location.
The anisotropic conductive layer may comprise at least one nonconductive location, wherein the at least one nonconductive location comprises at least one electrically insulated particle (262) of the plurality of electrically conductive particles, the at least one electrically insulated particle in electrical non-conductive relation with the at least one electrically connected particle. In at least another embodiment, the ACL includes the at least one nonconductive location.
The at least one conductive location may include at least one conductive protrusion abutting and electrically connected to the at least one electrically connected particle. In at least another embodiment, the ACL includes the at least one conductive protrusion.
The anisotropic conductive layer may be selected from the group consisting of a film, a paste, a tape and an adhesive.
The plurality of electrically conductive particles may be selected from the group consisting of metallic particles, metal-coated particles, electrically conductive composite particles and electrically conductive coated polymer, glass, glass-ceramic, or ceramic particles.
The first conductive pathway may comprise a leadwire (114), wherein the at least one conductive protrusion is an extended end of the leadwire or a nail head end (114NH) of the leadwire. The leadwire (114) may comprise two different materials (114 and 117) electrically connected.
The anisotropic conductive layer may be at least partially disposed between the insulator and the feedthrough capacitor, wherein the feedthrough capacitor may comprise a leadwire (111) disposed on the device side electrically connected to the capacitor active metallization, wherein the at least one conductive protrusion may be an extended end of the leadwire or a nail head end (111NH) of the leadwire.
The ferrule may include at least one surface (113) disposed on the device side with at least one pocket (248) formed in the at least one surface, and a gold pocket pad (250) may be disposed within the at least one pocket.
The capacitor ground metallization may be disposed on an exterior surface of the feedthrough capacitor and including an electrical connection material (152) electrically connecting the capacitor ground metallization to the gold pocket pad disposed within the at least one pocket.
The insulator may be alumina and hermetically seal the ferrule opening by a first gold braze (150), wherein the first gold braze and the gold pocket pad are not physically touching one another.
The insulator may be glass and hermetically seal the ferrule opening by a first glass seal.
The insulator may be alumina and hermetically seals the ferrule opening by a first gold braze (150), wherein the capacitor ground metallization may be disposed on an exterior surface of the feedthrough capacitor and including an electrical connection material (152) electrically connecting the capacitor ground metallization to the first gold braze.
At least a first edge (252) of the feedthrough capacitor may extend beyond a first outermost edge (256) of the ferrule, and wherein at least a second edge (254) of the feedthrough capacitor may not extend beyond a second outermost edge (258) of the ferrule.
The capacitor dielectric may have a k value greater than zero and up to 200, or a k value greater than 200 and up to 1000.
The capacitor ground metallization may not be disposed on an exterior surface of the feedthrough capacitor and may be disposed within a ground via hole in the feedthrough capacitor, wherein the ferrule may include a peninsula (139) or a bridge (141) extending into the ferrule opening, wherein a ground leadwire (111) may be electrically connected to the capacitor ground metallization, wherein the ground lead wire may be at least partially disposed within the ground via hole and electrically connected to the peninsula or the bridge.
The capacitor ground metallization may be at least partially disposed on an exterior surface of the feedthrough capacitor and is electrically connected to the ferrule, and a second capacitor ground metallization (142′) may be electrically connected to the at least one ground electrode plate and may be disposed within a ground via hole in the feedthrough capacitor, wherein the ferrule may include a peninsula (139) or a bridge (141) extending into the ferrule opening, wherein a ground leadwire (111) may be at least partially disposed within the ground via hole and electrically connected to the second capacitor ground metallization, wherein the ground lead may be electrically connected to the peninsula or the bridge.
The capacitor ground metallization may be at least partially disposed on an exterior surface of the feedthrough capacitor and may be electrically connected to the gold pocket pad, and a second capacitor ground metallization (142′) may be electrically connected to the at least one ground electrode plate and may be disposed within a ground via hole in the feedthrough capacitor, wherein the ferrule may include a peninsula (139) or a bridge (141) extending into the ferrule opening, wherein a ground leadwire (111) may be at least partially disposed within the ground via hole and electrically connected to the second capacitor ground metallization, wherein the ground lead may be electrically connected to the peninsula or the bridge.
A metal addition (251) may be electrically connected to the gold pocket pad, wherein the metal addition is a different material in comparison to the ferrule, and wherein at least a portion of the metal addition is disposed above the at least one surface (113) of the ferrule, wherein the anisotropic conductive layer electrically connects the capacitor ground metallization to the metal addition.
The insulator may comprise alumina ceramic, wherein the first conductive pathway may comprise a composite fill co-sintered with the alumina ceramic or a substantially pure platinum fill co-sintered with the alumina ceramic, the fill extending from the body fluid side to the device side, wherein the first fill end is disposed at or adjacent to the device side of the insulator body, and wherein the second fill end is disposed at or adjacent to the body fluid side of the insulator body, wherein the composite fill comprises a ceramic reinforced metal composite comprising alumina and platinum and a substantially pure platinum fill or a metallic wire. A metallic end cap may be co-sintered into the composite fill, wherein at least a portion of the metallic end cap extends beyond a device side surface of the insulator and is electrically connected to the capacitor active metallization by the anisotropic conductive layer.
Thus, the present invention relates to a filtered feedthrough that is attachable to an active implantable medical device (AIMD), the filtered feedthrough comprising: a ferrule configured to be installed in an opening of a housing of the AIMD, the ferrule comprising a ferrule opening extending to a ferrule body fluid side opposite a ferrule device side, wherein, when the ferrule is installed in the opening of the AIMD housing, the ferrule body fluid side and the ferrule device side reside outside the housing and inside the housing, respectively; and an insulator hermetically sealed in the ferrule opening, the insulator having at least one via hole extending therethrough to an insulator body fluid side and an insulator device side; an insulator conductive pathway disposed through and hermetically sealed to the insulator in the at least one via hole, wherein the insulator conductive pathway comprises an insulator conductive pathway body fluid side end disposed adjacent to the insulator body fluid side and an insulator conductive pathway device side end disposed adjacent to the insulator device side; a filter capacitor disposed on the ferrule device side, the filter capacitor comprising: a dielectric substrate supporting at least one active electrode plate interleaved in a capacitive relationship with at least one ground electrode plate, wherein the dielectric substrate extends to a dielectric substrate device side opposite a dielectric substrate body fluid side; a first passageway disposed through the dielectric substrate; a capacitor active conductive pathway extending through the first passageway in the dielectric substrate and being electrically connected to the at least one active electrode plate, wherein a capacitor active conductive pathway device side end resides adjacent to the dielectric substrate devise side and a capacitor active conductive pathway body fluid side end resides adjacent to the dielectric substrate body fluid side; and a capacitor ground metallization disposed on an outer surface of the capacitor dielectric substrate and being electrically connected to the at least one ground electrode plate, an anisotropic conductive layer disposed between the capacitor dielectric substrate body fluid side and the insulator device side and comprising an electrically insulative matrix supporting a plurality of electrically conductive particles, wherein the anisotropic conductive layer comprises: a first thickness that is longitudinally aligned with the capacitor active conductive pathway body fluid side end and the insulator conductive pathway device side end; and a second, greater thickness where the capacitor active conductive pathway body fluid side end and the insulator conductive pathway device side end are not longitudinally aligned, wherein the first thickness provides at least one longitudinally aligned electrically conductive particle being in contact with the capacitor active conductive pathway body fluid side end and the insulator conductive pathway device side end to thereby provide electrical continuity from the capacitor active conductive pathway device side end to the insulator conductive pathway body fluid side end; and a first electrically conductive material electrically connecting the capacitor ground metallization to the ferrule.
In one embodiment of the present invention, at least one of the capacitor active conductive pathway body fluid side end and the insulator conductive pathway device side end is proud of the respective capacitor dielectric substrate body fluid side and the insulator device side, and wherein the first thickness of the anisotropic conductive layer is longitudinally aligned with the at least one proud capacitor active conductive pathway body fluid side end and the insulator conductive pathway device side end, and wherein the second, greater thickness resides where the at least one proud capacitor active conductive pathway body fluid side end and the insulator conductive pathway device side end are not longitudinally aligned.
The accompanying drawings illustrate the invention. In such drawings:
In accordance with the present invention, an anisotropic conductive layer (ACL) 212′ is disposed between the device side of the hermetic seal insulator 120 and the bottom of the feedthrough capacitor subassembly 132. As taught herein for any of the embodiments disclosed, it will be understood by those skilled in the art that the anisotropic conductive layer could be a film, paste, tape, adhesive, epoxy or the like that has an electrically insulative matrix 213 with a plurality of conductive particles 262 disposed therein, the conductive particles also generally in non-conductive relation to one another. Accordingly, throughout this application the anisotropic conductive layer can and will be referred to as an anisotropic conductive adhesive (ACA) or an anisotropic conductive film (ACF).
In more detail, anisotropic conductive adhesives (ACA) may comprise films, pastes, tapes or epoxies. Anisotropic conductive films (ACF) or tapes may be supplied in reels wherein the film or tape only needs to be cut to a suitable size and placed between the feedthrough capacitor 132 and the hermetic seal subassembly 120. Anisotropic conductive pastes (ACP) or epoxies may be applied either by printing or by dispensing with a syringe. It is contemplated that the method of manufacture will align with the selected ACL type.
The conductive particles within the matrix may comprise metallic particles, metal-coated particles, electrically conductive composite particles, or electrically conductive coated polymer, glass, glass-ceramic, or ceramic particles. Conductive additives, fillers, particles, materials or components to the adhesive, matrix, epoxy or resin in order to obtain a degree of electrical conductivity by its addition may include metals, carbon particles, conductive fibers, platelets, flakes, tubes, foils, whiskers, or irregularly shaped conductive constituents. Metal coated particle core options include polymers, composites, meshes, screens, braids, foamed materials, custom fiber or wire forms, pressed powders, pressed material clumps, either as formed or infiltrated with either an elastomeric, semi-rigid or rigid material prior to coating. The conductive particles may be compressible, rigid or combinations thereof. Either the matrix for the particles, the conductive particles within the matrix, or both the matrix and the conductive particles there within may be homogeneous or heterogeneous, where the matrix may be of a single homogeneous material, a composite of more than one material, a thermoplastic-thermoset polymer composite, a composite of two materials having different softening and/or cure temperatures, or an epoxy resin. The matrix and/or resin materials may be designed to strengthen a joint, manage thermal expansion and/or shrinkage, tolerate assembly or tolerate operational, intermittent or continuous, perturbations such as shock, vibration or temperature extremes. The conductive particle size within the matrix may be all the same or of different sizes, the average size having a distribution defined by application use. The conductive particle shape may be spherical, elliptical, elongated, rectangular, triangular, square, cubic, trapezoidal, tabular, irregular, dendritic, flake, platelet, fiber, tubular, angular, symmetric and/or asymmetric.
As used herein, the terms polymer, film, tape, resin, paste, matrix, epoxy and resin are used interchangeably. Likewise, the terms additive(s), filler(s) and particle(s) are also used interchangeably. It will be appreciated by one of ordinary skill in the art that volume %>20 may be used for certain applications, for example, when custom formulations require specific particle size and/or shape distributions. In some cases, spacers may be added and/or applied to inhibit shorting. The word “matrix” as used herein means a material (substrate, carrier, medium, structure) in which something develops, as the electrically insulative matrix is subjected to heat and pressure to affect the electrical connections of the conductive particles disposed therein.
As used herein, the term “anisotropic” means that the adhesive matrix is electrically insulative in the X and Y axes while being electrical conductive at selected locations in the Z axis after heat and pressure is applied such that the conductive particles are selectively compressed. As defined herein the Z axis is generally defined as the longitudinal axis.
As shown in
Referring once again to
Thus, this thermo-compression bonding comprises simultaneously applying heat and pressure to an assembly stack-up comprising an ACL disposed between at least two component surfaces. Heat and pressure are continuously applied until the embedded particles within the matrix (adhesive/film/paste matrix) sufficiently bridge, thereby electrically connecting two conductor surfaces, and is held at temperature and pressure until sufficient curing of the matrix achieves adhesion and/or curing. The electrical connection bridge is formed when the conductive particles become locked between the conductive areas of the mating surfaces. Under pressure and heat, the non-conductive matrix shrinks and forms a stable mechanical connection between two surfaces while the conductive particles within the matrix coalesce forming the electrical connection paths between at least two conductive elements on a surface or between two mating surfaces. Because of the anisotropy, ACLs may be deposited over an entire contact region without concern of shorting between conductors. Moreover, as an example ACLs easily enable connection for high-density conductors of greater than 100 (or 1000) and/or multi-conductor components requiring ultra-fine pitch connections of less than 0.04 mm. Pitch capability of ACLs are customizable by adjusting conductive filler particle shape, size and/or distribution.
ACL conductive particle content may be as low as from about 1% to about 5%. Alternatively, conductive particle content may range from about 1% to about 20%. Yet, another alternative is a conductive particle content ranging from about 1% to about 50%. While a low volume loading is typically used, because low loading is generally insufficient for inter-particle contact and essentially prevents electrical conductivity in the X-Y axes (X-Y plane) of the adhesive, loading may be particularly important when the filler or particles are compressible, as the application of vertical pressure during bonding elongates particles, increasing the possibility for inter-particle contact.
In addition to allowing the adhesive to flow, the applied heat also cures the anisotropic conductive layer, such that it adheres or becomes adhesive to both the capacitor and at least one of the hermetic seal insulator or ferrule mounting surfaces. When the heat and the force is removed, the capacitor 132 is then firmly attached to the hermetic seal subassembly 120, and the conductive spheres remain in place and in electrical contact with nail heads 111NH and 114NH.
This is better understood by referring to
Referring again to
Accordingly, the hermetic feedthrough assembly of
U.S. Pat. No. 5,905,627 describes internally grounded capacitors, the contents of which are incorporated herein fully by reference. Also, describing internally grounded capacitors are U.S. Pat. Nos. 6,529,103 and 6,765,780, the contents of which are also incorporated fully herein by reference.
Referring to
Referring once again to
Referring back to
Referring once again to
The feedthrough capacitor of
As previously discussed, the feedthrough capacitor 132′ is manufactured in a separate manufacturing operation in the hermetic seal subassembly 120. After the feedthrough capacitor is manufactured, then the nail headed leads 111, 111NH are installed by soldering 156 or the like. These nail heads are important because they stand proud of the capacitor mounting surface such that they can compress the conductive spheres 262′ in the ACF film 212′. When the capacitor's mounted against the hermetic seal insulator and against the ACF film, the ACF films are compressed in the area of the nail heads against the co-sintered conductive vias 185, 186, as illustrated. It will be appreciated that the ACF film is also compressed in the area of the ground nail heads 111gndNH, as indicated.
The novel nail head structures 111NH and 111gndNH, as illustrated in
Referring back to
In summary
Also, importantly, the conductive spheres 262′ disposed on the body fluid side in the ACL must also be biocompatible, non-toxic and biostable. This limits the ACL to use the following materials: palladium, niobium, platinum, iridium, titanium, carbon, gold, combinations thereof and/or alloys thereof. More specifically, carbon includes amorphous carbon, graphite, graphene, diamond-like carbon, vitreous carbon, pyrolytic carbon, carbon-carbon composites and/or combinations thereof. These carbon materials may comprise whiskers, platelets, sheets, fibers, needles, nano-tubes, spheres, crumpled balls, irregularly shaped carbon agglomerates or combinations thereof. The conductive spheres of the biocompatible ACL may also comprise a number of other biocompatible metals, such as tantalum, zirconium, hafnium, nitinol, ZrC, ZrN, TIN, NbO, TiC or TaC, stainless steel, cobalt-chromium (Co—Cr) alloys, molybdenum, silver and combinations thereof and/or alloys thereof. These materials may not be completely oxide resistant and therefore, to improve their conductivity, any of the following materials may be alloyed with any of the others, or may be such as coated, clad, or plated with a layer of any of the highly conductive oxide resistant biocompatible materials, for example, but not limited to, gold, platinum, palladium and the like. An example would be a titanium conductive sphere 262′, which has been platinum, palladium or gold plated. Other metals that are ideal for conductive spheres 262′ may include: the platinum group metals or noble metals, which also include palladium, rhodium, ruthenium, iridium and osmium. As stated before, any of these materials can be additionally coated, clad or plated with a layer of conductive oxide resistant materials. Stainless steels, in general, can also be considered to be conductive particles, particularly those offering biocompatibility, such as, but not limited to, alloy 316L.
Biocompatibility and non-toxicity means the materials used have to meet certain rigorous criteria. However, biostability, in the presence of electrical pulses, becomes a whole other matter. One needs to demonstrate that over time, the materials used do not migrate or electroplate in the presence of body fluids (saline) and electrical impulses. It is well known in the plating industry that one can plate precious metal, such as gold or platinum, onto other surfaces by the use of conductive paths and proper electrical polarities (electro-plating). Accordingly, the inventors had to take all of these properties into account to provide a list of materials that would make suitable candidates for implantation on the body fluid side.
Referring once again to
The inventors did a careful examination of the prior art and did find a case where ACF films are mentioned in conjunction with a hermetic seal for an implanted medical device. This is in U.S. Pat. No. 9,174,047, the contents of which are herein incorporated fully by reference. The following is quoted from the '047 patent from column 6, lines 28 through 42 and reads on FIG. 4B, and is as follows: “On the interior side of the electrical feedthrough (405), connections (407) may be made between the hybrid circuit (422) and the feedthrough (405). According to one illustrative embodiment, the hybrid (422) is attached to the underlying electrical feedthrough (405) using a blind attachment technique. Blind attachment refers to situations where only one side of a work piece is accessible for component assembly and making electrical connections. In this case, the hybrid circuit (422) may entirely cover the electrical feedthrough (405), rendering it not visible during the attachment process. The blind attachment may be done using a variety of methods, including, but not limited to the anisotropic conductive film, anisotropic conductive paste, conductive epoxy, conductive silicone, solder, ball grid array and other compatible approaches.”
The problem with this kind of a laundry list spanning ACF films, solder and to other compatible approaches is that none of them are enabled. For example, nowhere in the '047 patent is the creation of proud flat surfaces done either on the hermetic seal side or on the circuit board side, that would lead to a reliable compression of conductive particles in an ACF paste or film. This contrasts with the present invention which goes to a great deal of effort to create nail heads or very proud flat surfaces to reliably compress particles in an ACF film. In addition, the '047 patent does not discuss primary filtering or feedthrough capacitor at all for an active implantable medical device. ACF films have been used many times to connect circuit boards to flexible circuit boards or to LCD screens and the like, however, no one has ever contemplated using ACF films to make a connection between a feedthrough capacitor and an adjacent hermetic feedthrough terminal for an AIMD. Importantly, feedthrough capacitors are disposed directly at the point of leadwire ingress to an AIMD to divert dangerous high-frequency energy immediately to the housing before it can enter and re-radiate to sensitive electronics. In addition, there is no mention whatsoever in the '047 patent (or any other prior art that the inventors can find) that contemplate the use of a biocompatible ACF film on the body fluid side of a hermetic insulator for an AIMD. It is well known that even if the AIMD has a header block, such as cardiac pacemaker, that the header block, which may be a plastic, such as Tecothane®, does not prevent over time the entry of body fluids due to a process known as bulk permeability. To understand bulk permeability, one needs to understand the military and space industry has outlawed any adjunct salient over a hermetic seal. A true hermetic seal is generally, in this context, a gold brazed alumina ceramic seal capable of leak rates greater than 1×10-7 std. cc He/s. To understand bulk permeability, one need look no further than the antique glass fishing floats that are sometimes found hanging on nets, for example outside a restaurant in Cape Cod. Close examination reveals that sometimes these so-called solid hollow glass balls are half full of water or more. That water, over time, enters through changes in temperature and humidity and over time, the water vapor passes right through the glass and ends up condensing on the inside as water, Such an occurrence would be a disaster for the sensitive electronic circuits of an active implantable medical device. What this means is that any electrical connection on the body fluid side of a hermetic terminal for an AIMD must be completely biocompatible, biostable and non-toxic. It must be assumed that over time, water will reach this area since it is not inside a hermetically sealed area. Therefore, only very special materials as taught herein, in compositions for ACF films can be used. In summary, the '047 patent teaches nothing about using nail heads through circuit boards to create continuous electrical paths and proud surfaces nor does it teach anything about the mounting of a feedthrough capacitor, nor does it teach anything about biocompatibility of an ACF film.
Before the ceramic lid 116C′ is laser welded 154′ to the ceramic base 1160, an electronic package is first manufactured and installed, like a ship in a bottle. Referring once again to
In this case, the circuit board has an energy transfer module 442, as indicated. This can be an inductive loop with many turns of wire, or a tuned LC circuit or the like. Its purpose is to capture electromagnetic energy 446 from an external RF power transmitting source, such that this energy can be captured by the AIMD of
Referring once again to
On the right-hand side of
As previously mentioned, this is a ship-in-the-bottle kind of a construction where the assembly work is done first, so that, final testing of the circuit board and all of its components, including high reliability procedures, such as elevated temperature burn-in, could be performed. It is at this time, that the entire circuit board and all of its components are slipped down inside the ceramic housing 116C until the opposed weld rings are seated against each other. At this point, the inside of the unit is evacuated in a vacuum and then backfilled with an inert gas, such as nitrogen with a trace of helium for helium leak detection. A continuous laser weld 154′ is made all the way around the seam between the upper and lower titanium weld rings unit, which mechanically attaches the upper lid 116C′ to the bottom housing 116C and therefore, also hermetically seals it.
Similar to
Referring once again to
The headings (such as “Introduction” and “Summary”) and sub-headings used herein are intended only for general organization of topics within the present disclosure and are not intended to limit the disclosure of the technology or any aspect thereof. In particular, subject matter disclosed in the “Introduction” may include novel technology and may not constitute a recitation of prior art. Subject matter disclosed in the “Summary” is not an exhaustive or complete disclosure of the entire scope of the technology or any embodiments thereof. Classification or discussion of a material within a section of this specification as having a particular utility is made for convenience, and no inference should be drawn that the material must necessarily or solely function in accordance with its classification herein when it is used in any given composition.
The citation of references herein does not constitute an admission that those references are prior art or have any relevance to the patentability of the technology disclosed herein. All references cited in the “Detailed Description” section of this specification are hereby incorporated by reference in their entirety.
The description and specific examples, while indicating embodiments of the technology, are intended for purposes of illustration only and are not intended to limit the scope of the technology. Moreover, recitation of multiple embodiments having stated features is not intended to exclude other embodiments having additional features, or other embodiments incorporating different combinations of the stated features. Specific examples are provided for illustrative purposes of how to make and use the apparatus and systems of this technology and, unless explicitly stated otherwise, are not intended to be a representation that given embodiments of this technology have, or have not, been made or tested.
As referred to herein, all compositional percentages are by weight of the total composition, unless otherwise specified. As used herein, the word “include,” and its variants, is intended to be non-limiting, such that recitation of items in a list is not to the exclusion of other like items that may also be useful in the materials, compositions, devices, and methods of this technology. Similarly, the terms “can” and “may” and their variants are intended to be non-limiting, such that recitation that an embodiment can or may comprise certain elements or features does not exclude other embodiments of the present technology that do not contain those elements or features.
As used herein, ACL is an acronym for an Anisotropic Conductive Layer. Anisotropic Conductive Adhesive (ACA), Anisotropic Conductive Film (ACF), Anisotropic Conductive Paste (ACP), anisotropic conductive tape, and anisotropic conductive epoxy are all types of ACL. Throughout this patent specification, ACF or Anisotropic Conductive Film is used as an example; however, it is understood that, anywhere ACF or Anisotropic Conductive Film is specified or described, any type of ACL can also be used. Additionally, it is contemplated that any type of ACL may be used alone or in combination with one or more other or different ACL type.
“A” and “an” as used herein indicate “at least one” of the item is present, which also includes the possibility of a plurality of such items being present. “About” when applied to values indicates that the calculation or the measurement allows some slight imprecision in the value (with some approach to exactness in the value; approximately or reasonably close to the value; nearly). If, for some reason, the imprecision provided by “about” is not otherwise understood in the art with this ordinary meaning, then “about” as used herein indicates at least variations that may arise from ordinary methods of measuring or using such parameters. In addition, disclosure of ranges includes disclosure of all distinct values and further divided ranges within the entire range.
This is a continuation application of U.S. application Ser. No. 16/362,043, filed on Mar. 22, 2019, now U.S. Pat. No. 10,905,888, which is a continuation-in-part application of U.S. application Ser. No. 16/121,716, filed on Sep. 5, 2018, now U.S. Pat. No. 10,596,369, which is a continuation-in-part application of U.S. application Ser. No. 15/943,998, filed on Apr. 3, 2018, now U.S. Pat. No. 10,350,421, which claims priority to U.S. provisional application Ser. No. 62/646,522, filed on Mar. 22, 2018, the contents of which are fully incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3681612 | Kinzler et al. | Aug 1972 | A |
3745430 | Lunquist et al. | Jul 1973 | A |
3871382 | Mann | Mar 1975 | A |
3882248 | Stevenson et al. | May 1975 | A |
3961294 | Hollyday | Jun 1976 | A |
3968802 | Ballis | Jul 1976 | A |
3980975 | Maxon et al. | Sep 1976 | A |
3985775 | Harrison et al. | Oct 1976 | A |
4188598 | Hunt | Feb 1980 | A |
4236127 | Scherba | Nov 1980 | A |
4295467 | Mann et al. | Oct 1981 | A |
4320763 | Money | Mar 1982 | A |
4424551 | Stevenson et al. | Jan 1984 | A |
4431005 | McCormick | Feb 1984 | A |
4437474 | Peers-Trevarton et al. | Mar 1984 | A |
4445501 | Bresler | May 1984 | A |
4572198 | Codrington | Feb 1986 | A |
4585001 | Belt | Apr 1986 | A |
4633181 | Murphy-Boesch et al. | Dec 1986 | A |
4643186 | Rosen et al. | Feb 1987 | A |
4654880 | Sontag | Mar 1987 | A |
4672972 | Berke | Jun 1987 | A |
4689621 | Kleinberg | Aug 1987 | A |
4712555 | Thornander et al. | Dec 1987 | A |
4746864 | Satoh et al. | May 1988 | A |
4754752 | Ginsburg et al. | Jul 1988 | A |
4757820 | Itoh | Jul 1988 | A |
4766381 | Conturo et al. | Aug 1988 | A |
4788980 | Mann et al. | Dec 1988 | A |
4799499 | Bisping | Jan 1989 | A |
4813429 | Eshel et al. | Mar 1989 | A |
4823812 | Eshel et al. | Apr 1989 | A |
4832023 | Murphy-Chutorian et al. | May 1989 | A |
4858064 | Segawa et al. | Aug 1989 | A |
4858623 | Bradshaw et al. | Aug 1989 | A |
4859950 | Keren | Aug 1989 | A |
4932411 | Fritschy et al. | Jun 1990 | A |
4940052 | Mann et al. | Jul 1990 | A |
4944298 | Sholder | Jul 1990 | A |
4960106 | Kubokawa et al. | Oct 1990 | A |
4989608 | Ratner | Feb 1991 | A |
4991580 | Moore | Feb 1991 | A |
5011995 | Pugin et al. | Apr 1991 | A |
5019075 | Spears et al. | May 1991 | A |
5039965 | Higgins | Aug 1991 | A |
5044375 | Bach et al. | Sep 1991 | A |
5052404 | Hodgson et al. | Oct 1991 | A |
5063348 | Kuhara et al. | Nov 1991 | A |
5066136 | Johnson | Nov 1991 | A |
5095911 | Pomeranz | Mar 1992 | A |
5099208 | Fitzpatrick et al. | Mar 1992 | A |
5167233 | Eberle et al. | Dec 1992 | A |
5178618 | Kandarpa | Jan 1993 | A |
5190046 | Shturman | Mar 1993 | A |
5197468 | Proctor et al. | Mar 1993 | A |
5209233 | Holland et al. | May 1993 | A |
5211165 | Dumoulin et al. | May 1993 | A |
5217010 | Tsitlik et al. | Jun 1993 | A |
5222506 | Patrick et al. | Jun 1993 | A |
5246438 | Langberg | Sep 1993 | A |
5251120 | Smith | Oct 1993 | A |
5268810 | Dimarco et al. | Dec 1993 | A |
5271400 | Dumoulin et al. | Dec 1993 | A |
5300108 | Rebell et al. | Apr 1994 | A |
5306291 | Kroll et al. | Apr 1994 | A |
5307808 | Dumoulin et al. | May 1994 | A |
5307814 | Kressel | May 1994 | A |
5318025 | Dumoulin et al. | Jun 1994 | A |
5323776 | Blakeley et al. | Jun 1994 | A |
5323778 | Kandarpa et al. | Jun 1994 | A |
5331505 | Wilheim | Jul 1994 | A |
5333095 | Stevenson | Jul 1994 | A |
5334045 | Cappa et al. | Aug 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5348010 | Schnall et al. | Sep 1994 | A |
5352979 | Conturo | Oct 1994 | A |
5358515 | Hurter et al. | Oct 1994 | A |
5363845 | Chowdhury et al. | Nov 1994 | A |
5365928 | Rhinehart et al. | Nov 1994 | A |
5370644 | Langberg | Dec 1994 | A |
5398683 | Edwards et al. | Mar 1995 | A |
5400787 | Marandos | Mar 1995 | A |
5404880 | Throne | Apr 1995 | A |
5413104 | Buijs et al. | May 1995 | A |
5419325 | Dumoulin et al. | May 1995 | A |
5428337 | Mnclarelli et al. | Jun 1995 | A |
5433717 | Rubinsky et al. | Jul 1995 | A |
5437277 | Dumoulin et al. | Aug 1995 | A |
5443066 | Dumoulin et al. | Aug 1995 | A |
5443489 | Ben-Haim | Aug 1995 | A |
5447156 | Dumoulin et al. | Sep 1995 | A |
5450090 | Gels et al. | Sep 1995 | A |
5451232 | Rhinehart et al. | Sep 1995 | A |
5462055 | Casey et al. | Oct 1995 | A |
5466254 | Helland | Nov 1995 | A |
5476095 | Schnall et al. | Dec 1995 | A |
5476483 | Bornzin et al. | Dec 1995 | A |
5491300 | Huppenthal et al. | Feb 1996 | A |
5493259 | Blalock et al. | Feb 1996 | A |
5498261 | Strul | Mar 1996 | A |
5507743 | Edwards et al. | Apr 1996 | A |
5512825 | Atalar et al. | Apr 1996 | A |
5514173 | Rebell et al. | May 1996 | A |
5540679 | Fram et al. | Jul 1996 | A |
5545201 | Helland et al. | Aug 1996 | A |
5558093 | Pomeranz | Sep 1996 | A |
5578008 | Hara | Nov 1996 | A |
5588432 | Crowley | Dec 1996 | A |
5590657 | Cain et al. | Jan 1997 | A |
5591218 | Jacobson | Jan 1997 | A |
5620476 | Truex et al. | Apr 1997 | A |
5623241 | Minkoff | Apr 1997 | A |
5623724 | Gurkovich et al. | Apr 1997 | A |
5629622 | Scampini | May 1997 | A |
5650759 | Hittman et al. | Jul 1997 | A |
5662108 | Budd et al. | Sep 1997 | A |
5682897 | Pomeranz | Nov 1997 | A |
5683435 | Truex et al. | Nov 1997 | A |
5685878 | Falwell et al. | Nov 1997 | A |
5699801 | Atalar et al. | Dec 1997 | A |
5700548 | Warnier et al. | Dec 1997 | A |
5706810 | Rubinsky et al. | Jan 1998 | A |
5715825 | Crowley | Feb 1998 | A |
5716390 | Li | Feb 1998 | A |
5722998 | Prutchi et al. | Mar 1998 | A |
5735884 | Thompson et al. | Apr 1998 | A |
5735887 | Barreras et al. | Apr 1998 | A |
5741321 | Brennen | Apr 1998 | A |
5751539 | Stevenson et al. | May 1998 | A |
5757252 | Cho et al. | May 1998 | A |
5759202 | Schroeppel | Jun 1998 | A |
5765779 | Hancock et al. | Jun 1998 | A |
5769800 | Gelfand et al. | Jun 1998 | A |
5772693 | Brownlee | Jun 1998 | A |
5775338 | Hastings | Jul 1998 | A |
5779669 | Haissaguerre et al. | Jul 1998 | A |
5782891 | Hassler et al. | Jul 1998 | A |
5792055 | McKinnon | Aug 1998 | A |
5800467 | Park et al. | Sep 1998 | A |
5822174 | Yamate et al. | Oct 1998 | A |
5824026 | Diaz et al. | Oct 1998 | A |
5824029 | Weijand et al. | Oct 1998 | A |
5833608 | Acker | Nov 1998 | A |
5836992 | Thompson et al. | Nov 1998 | A |
5840031 | Crowley | Nov 1998 | A |
5851226 | Skubitz et al. | Dec 1998 | A |
5855995 | Haq et al. | Jan 1999 | A |
5864234 | Luedeke | Jan 1999 | A |
5867361 | Seifried et al. | Feb 1999 | A |
5868674 | Glowinski et al. | Feb 1999 | A |
5871091 | Fogle et al. | Feb 1999 | A |
5879347 | Saadat | Mar 1999 | A |
5891134 | Goble et al. | Apr 1999 | A |
5896267 | Hittman et al. | Apr 1999 | A |
5905627 | Brendel et al. | May 1999 | A |
5916162 | Snelten et al. | Jun 1999 | A |
5928145 | Ocali et al. | Jul 1999 | A |
5928159 | Eggers et al. | Jul 1999 | A |
5929729 | Swarup | Jul 1999 | A |
5934588 | Ylikangas et al. | Aug 1999 | A |
5938609 | Pomeranz | Aug 1999 | A |
5938692 | Rudie | Aug 1999 | A |
5959336 | Barsan | Sep 1999 | A |
5959829 | Stevenson et al. | Sep 1999 | A |
5964705 | Truwit et al. | Oct 1999 | A |
5973906 | Stevenson et al. | Oct 1999 | A |
5973907 | Reed | Oct 1999 | A |
5978204 | Stevenson | Nov 1999 | A |
5985347 | Ejnik | Nov 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6026316 | Kucharczyk et al. | Feb 2000 | A |
6027500 | Buckles et al. | Feb 2000 | A |
6031375 | Atalar et al. | Feb 2000 | A |
6031710 | Wolf et al. | Feb 2000 | A |
6041496 | Haq et al. | Mar 2000 | A |
6045532 | Eggers et al. | Apr 2000 | A |
6055457 | Bonner | Apr 2000 | A |
6099524 | Lipson et al. | Aug 2000 | A |
6101417 | Vogel et al. | Aug 2000 | A |
6128522 | Acker et al. | Oct 2000 | A |
6129670 | Burdette et al. | Oct 2000 | A |
6137161 | Gilliland et al. | Oct 2000 | A |
6141594 | Flynn et al. | Oct 2000 | A |
6146743 | Haq et al. | Nov 2000 | A |
6159560 | Stevenson et al. | Dec 2000 | A |
6171240 | Young et al. | Jan 2001 | B1 |
6171241 | McVeigh et al. | Jan 2001 | B1 |
6188219 | Reeder et al. | Feb 2001 | B1 |
6198972 | Hartlaub et al. | Mar 2001 | B1 |
6209764 | Hartlaub et al. | Apr 2001 | B1 |
6226545 | Gilderdale | May 2001 | B1 |
6236205 | Lüdeke et al. | May 2001 | B1 |
6238390 | Tu et al. | May 2001 | B1 |
6252761 | Branchevsky | Jun 2001 | B1 |
6263229 | Atalar et al. | Jul 2001 | B1 |
6272370 | Gillies et al. | Aug 2001 | B1 |
6275369 | Stevenson et al. | Aug 2001 | B1 |
6275379 | Sleboda et al. | Aug 2001 | B1 |
6280385 | Melzer et al. | Aug 2001 | B1 |
6284080 | Haq et al. | Sep 2001 | B1 |
6284971 | Atalar et al. | Sep 2001 | B1 |
6332089 | Acker et al. | Dec 2001 | B1 |
6370427 | Alt et al. | Apr 2002 | B1 |
6373673 | Anthony | Apr 2002 | B1 |
6390996 | Halperin et al. | May 2002 | B1 |
6395637 | Park et al. | May 2002 | B1 |
6408202 | Lima et al. | Jun 2002 | B1 |
6414835 | Wolf et al. | Jul 2002 | B1 |
6424234 | Stevenson | Jul 2002 | B1 |
6428537 | Swanson et al. | Aug 2002 | B1 |
6433653 | Matsumura et al. | Aug 2002 | B1 |
6456481 | Stevenson | Sep 2002 | B1 |
6459935 | Piersma | Oct 2002 | B1 |
6470545 | Branchevsky | Oct 2002 | B1 |
6473291 | Stevenson | Oct 2002 | B1 |
6473314 | Custer et al. | Oct 2002 | B1 |
6486529 | Chi et al. | Nov 2002 | B2 |
6493591 | Stokes | Dec 2002 | B1 |
6512666 | Duva | Jan 2003 | B1 |
6529103 | Brendel et al. | Mar 2003 | B1 |
6535766 | Thompson et al. | Mar 2003 | B1 |
6539253 | Thompson et al. | Mar 2003 | B2 |
6539261 | Dal Molin | Mar 2003 | B2 |
6549800 | Atalar et al. | Apr 2003 | B1 |
6556009 | Kellman et al. | Apr 2003 | B2 |
6566978 | Stevenson et al. | May 2003 | B2 |
6567259 | Stevenson et al. | May 2003 | B2 |
6567703 | Thompson et al. | May 2003 | B1 |
6593884 | Gilboa et al. | Jul 2003 | B1 |
6606513 | Lardo et al. | Aug 2003 | B2 |
6615483 | Lindegren | Sep 2003 | B2 |
6628980 | Atalar et al. | Sep 2003 | B2 |
6633780 | Berger | Oct 2003 | B1 |
6643903 | Stevenson et al. | Nov 2003 | B2 |
6654628 | Silber et al. | Nov 2003 | B1 |
6660116 | Wolf | Dec 2003 | B2 |
6675033 | Lardo et al. | Jan 2004 | B1 |
6675036 | Kreger et al. | Jan 2004 | B2 |
6675779 | King et al. | Jan 2004 | B2 |
6675780 | Wendels et al. | Jan 2004 | B1 |
6687550 | Doan | Feb 2004 | B1 |
6690963 | Ben-Haim et al. | Feb 2004 | B2 |
6694583 | Branchevsky | Feb 2004 | B2 |
6697675 | Safarevich et al. | Feb 2004 | B1 |
6697958 | Yada et al. | Feb 2004 | B1 |
6701176 | Halperin et al. | Mar 2004 | B1 |
6714809 | Lee et al. | Mar 2004 | B2 |
6728575 | Hedberg | Apr 2004 | B2 |
6728579 | Lindgren et al. | Apr 2004 | B1 |
6759388 | Marchant et al. | Jul 2004 | B1 |
6765779 | Stevenson et al. | Jul 2004 | B2 |
6765780 | Brendel et al. | Jul 2004 | B2 |
6768630 | Togashi | Jul 2004 | B2 |
6771067 | Kellman et al. | Aug 2004 | B2 |
6795730 | Connelly et al. | Sep 2004 | B2 |
6806806 | Anthony | Oct 2004 | B2 |
6823215 | Obel et al. | Nov 2004 | B2 |
6829509 | MacDonald et al. | Dec 2004 | B1 |
6847837 | Melzer et al. | Jan 2005 | B1 |
6868288 | Thompson | Mar 2005 | B2 |
6876885 | Swoyer et al. | Apr 2005 | B2 |
6888715 | Stevenson et al. | May 2005 | B2 |
6898454 | Atalar et al. | May 2005 | B2 |
6901292 | Hrdlicka et al. | May 2005 | B2 |
6904307 | Karmarkar et al. | Jun 2005 | B2 |
6925328 | Foster et al. | Aug 2005 | B2 |
6930242 | Helfer et al. | Aug 2005 | B1 |
6931283 | Magnusson | Aug 2005 | B1 |
6931286 | Sigg et al. | Aug 2005 | B2 |
6944489 | Zeijlemaker et al. | Sep 2005 | B2 |
6944507 | Fröberg et al. | Sep 2005 | B2 |
6949929 | Gray et al. | Sep 2005 | B2 |
6950696 | Björling et al. | Sep 2005 | B2 |
6952613 | Swoyer et al. | Oct 2005 | B2 |
6971391 | Wang et al. | Dec 2005 | B1 |
6987660 | Stevenson et al. | Jan 2006 | B2 |
6999818 | Stevenson et al. | Feb 2006 | B2 |
7012192 | Stevenson et al. | Mar 2006 | B2 |
7013180 | Dougherty et al. | Mar 2006 | B2 |
7015393 | Weiner et al. | Mar 2006 | B2 |
7035076 | Stevenson | Apr 2006 | B1 |
7038900 | Stevenson et al. | May 2006 | B2 |
7039455 | Brosovich et al. | May 2006 | B1 |
7046499 | Imani et al. | May 2006 | B1 |
7047073 | Höijer et al. | May 2006 | B2 |
7050855 | Zeijlemaker et al. | May 2006 | B2 |
7068491 | Burdon et al. | Jun 2006 | B1 |
7091412 | Wang et al. | Aug 2006 | B2 |
7092766 | Salys et al. | Aug 2006 | B1 |
7110227 | Anthony et al. | Sep 2006 | B2 |
7113387 | Stevenson et al. | Sep 2006 | B2 |
7123013 | Gray | Oct 2006 | B2 |
7127294 | Wang et al. | Oct 2006 | B1 |
7136273 | Stevenson et al. | Nov 2006 | B2 |
7148783 | Parsche | Dec 2006 | B2 |
7149578 | Edvardsson | Dec 2006 | B2 |
7149773 | Haller et al. | Dec 2006 | B2 |
7155271 | Halperin et al. | Dec 2006 | B2 |
7162302 | Wang et al. | Jan 2007 | B2 |
7164572 | Burdon et al. | Jan 2007 | B1 |
7164950 | Kroll et al. | Jan 2007 | B2 |
7174219 | Wahlstrand et al. | Feb 2007 | B2 |
7174223 | Money et al. | Feb 2007 | B2 |
7199995 | Stevenson | Apr 2007 | B2 |
7211103 | Greenberg et al. | May 2007 | B2 |
7236816 | Kumar et al. | Jun 2007 | B2 |
7236834 | Christopherson et al. | Jun 2007 | B2 |
7276474 | Marchant et al. | Oct 2007 | B2 |
7301748 | Anthony et al. | Nov 2007 | B2 |
7310216 | Stevenson et al. | Dec 2007 | B2 |
7319905 | Morgan et al. | Jan 2008 | B1 |
7322832 | Kronich et al. | Jan 2008 | B2 |
7327553 | Brendel | Feb 2008 | B2 |
7363090 | Halperin et al. | Apr 2008 | B2 |
7369898 | Kroll et al. | May 2008 | B1 |
7387928 | Cheung | Jun 2008 | B2 |
7388378 | Gray et al. | Jun 2008 | B2 |
7422568 | Yang et al. | Sep 2008 | B2 |
7423860 | Anthony et al. | Sep 2008 | B2 |
7428136 | Barnett | Sep 2008 | B2 |
7433168 | Anthony | Oct 2008 | B2 |
7436672 | Ushijima et al. | Oct 2008 | B2 |
7439449 | Kumar et al. | Oct 2008 | B1 |
7446996 | Togashi | Nov 2008 | B2 |
7450396 | Ye et al. | Nov 2008 | B2 |
7480988 | Ok et al. | Jan 2009 | B2 |
7489495 | Stevenson | Feb 2009 | B2 |
7495884 | Togashi | Feb 2009 | B2 |
7517769 | Van Schuylenbergh et al. | Apr 2009 | B2 |
7529590 | MacDonald | May 2009 | B2 |
7535693 | Stevenson et al. | May 2009 | B2 |
7551963 | Rusin et al. | Jun 2009 | B2 |
7561906 | Atalar et al. | Jul 2009 | B2 |
7586728 | Anthony | Sep 2009 | B2 |
7593208 | Anthony et al. | Sep 2009 | B2 |
7623335 | Stevenson et al. | Nov 2009 | B2 |
7675729 | Anthony et al. | Mar 2010 | B2 |
7679926 | Hsu et al. | Mar 2010 | B2 |
7689288 | Stevenson et al. | Mar 2010 | B2 |
7693576 | Lavie et al. | Apr 2010 | B1 |
7702387 | Stevenson et al. | Apr 2010 | B2 |
7719854 | Youker et al. | May 2010 | B2 |
7729770 | Cabelka et al. | Jun 2010 | B2 |
7733621 | Anthony et al. | Jun 2010 | B2 |
7797048 | Stevenson et al. | Sep 2010 | B2 |
7812691 | Fisk et al. | Oct 2010 | B1 |
7839146 | Gray | Nov 2010 | B2 |
7844319 | Susil et al. | Nov 2010 | B2 |
7844343 | Wahlstrand et al. | Nov 2010 | B2 |
7853324 | Stevenson et al. | Dec 2010 | B2 |
7899551 | Westlund et al. | Mar 2011 | B2 |
7901761 | Jiang et al. | Mar 2011 | B1 |
7957806 | Stevenson et al. | Jun 2011 | B2 |
7989080 | Greenberg et al. | Aug 2011 | B2 |
8000804 | Wessendorf et al. | Aug 2011 | B1 |
8008980 | Moriya et al. | Aug 2011 | B2 |
8043454 | Jiang et al. | Oct 2011 | B1 |
8095224 | Truex et al. | Jan 2012 | B2 |
8131376 | Greenburg et al. | Mar 2012 | B1 |
8163397 | Ok et al. | Apr 2012 | B2 |
8179658 | Stevenson et al. | May 2012 | B2 |
8219208 | Stevenson et al. | Jul 2012 | B2 |
8301249 | Min | Oct 2012 | B2 |
8494635 | Guebler et al. | Jul 2013 | B2 |
8528201 | Guebler et al. | Sep 2013 | B2 |
8588916 | Satou et al. | Nov 2013 | B2 |
8604341 | Barry et al. | Dec 2013 | B2 |
8653384 | Tang et al. | Feb 2014 | B2 |
8659870 | Brendel et al. | Feb 2014 | B2 |
8670829 | Morioka et al. | Mar 2014 | B2 |
8755887 | Troetzschel et al. | Jun 2014 | B2 |
8763245 | Lucisano et al. | Jul 2014 | B1 |
8841558 | Satou et al. | Sep 2014 | B2 |
8855768 | Dabney et al. | Oct 2014 | B1 |
8872035 | Satou et al. | Oct 2014 | B2 |
8874206 | Malinowski et al. | Oct 2014 | B2 |
8886320 | Wollenberg et al. | Nov 2014 | B2 |
8927862 | Barry et al. | Jan 2015 | B2 |
8929987 | Troetzschel et al. | Jan 2015 | B2 |
8938309 | Marzano et al. | Jan 2015 | B2 |
9008779 | Satou et al. | Apr 2015 | B2 |
9032614 | Specht | May 2015 | B2 |
9108066 | Woods et al. | Aug 2015 | B2 |
9233253 | Stevenson et al. | Jan 2016 | B2 |
9407076 | Troetzschel et al. | Aug 2016 | B2 |
9418778 | Makino et al. | Aug 2016 | B2 |
9427596 | Brendel et al. | Aug 2016 | B2 |
9431814 | Blilie et al. | Aug 2016 | B2 |
9480168 | Troetzschel et al. | Oct 2016 | B2 |
9492659 | Brendel et al. | Nov 2016 | B2 |
9552899 | Specht et al. | Jan 2017 | B2 |
20020055678 | Scott et al. | May 2002 | A1 |
20020095197 | Lardo et al. | Jul 2002 | A1 |
20020177771 | Guttman et al. | Nov 2002 | A1 |
20020192688 | Yang et al. | Dec 2002 | A1 |
20030013928 | Saruwatari | Jan 2003 | A1 |
20030013948 | Russell | Jan 2003 | A1 |
20030028094 | Kumar et al. | Feb 2003 | A1 |
20030028095 | Tulley et al. | Feb 2003 | A1 |
20030050557 | Susil et al. | Mar 2003 | A1 |
20030053284 | Stevenson et al. | Mar 2003 | A1 |
20030083570 | Cho et al. | May 2003 | A1 |
20030083723 | Wilkinson et al. | May 2003 | A1 |
20030083726 | Zeijlemaker et al. | May 2003 | A1 |
20030140931 | Zeijlemaker et al. | Jul 2003 | A1 |
20030144704 | Terry et al. | Jul 2003 | A1 |
20030144705 | Funke | Jul 2003 | A1 |
20030144706 | Funke | Jul 2003 | A1 |
20030144716 | Reinke et al. | Jul 2003 | A1 |
20030144718 | Zeijlemaker | Jul 2003 | A1 |
20030144719 | Zeijlemaker | Jul 2003 | A1 |
20030144720 | Villaseca et al. | Jul 2003 | A1 |
20030144721 | Villaseca et al. | Jul 2003 | A1 |
20030171792 | Zarinetchi et al. | Sep 2003 | A1 |
20030179536 | Stevenson et al. | Sep 2003 | A1 |
20030204217 | Greatbatch | Oct 2003 | A1 |
20030208252 | O'Boyle et al. | Nov 2003 | A1 |
20030212373 | Hall et al. | Nov 2003 | A1 |
20030213605 | Brendel et al. | Nov 2003 | A1 |
20040015079 | Berger et al. | Jan 2004 | A1 |
20040034338 | Thierfelder et al. | Feb 2004 | A1 |
20040088012 | Kroll et al. | May 2004 | A1 |
20040167392 | Halperin et al. | Aug 2004 | A1 |
20040210289 | Wang et al. | Oct 2004 | A1 |
20040230271 | Wang et al. | Nov 2004 | A1 |
20040249428 | Wang et al. | Dec 2004 | A1 |
20040263173 | Gray | Dec 2004 | A1 |
20040263174 | Gray et al. | Dec 2004 | A1 |
20050007718 | Stevenson et al. | Jan 2005 | A1 |
20050070972 | Wahlstrand et al. | Mar 2005 | A1 |
20050113669 | Helfer et al. | May 2005 | A1 |
20050113676 | Weiner et al. | May 2005 | A1 |
20050113873 | Weiner et al. | May 2005 | A1 |
20050113874 | Connelly et al. | May 2005 | A1 |
20050113876 | Weiner et al. | May 2005 | A1 |
20050197677 | Stevenson | Sep 2005 | A1 |
20050201039 | Stevenson et al. | Sep 2005 | A1 |
20050215914 | Bornzin et al. | Sep 2005 | A1 |
20050222642 | Przybyszewski et al. | Oct 2005 | A1 |
20050222647 | Wahlstrand et al. | Oct 2005 | A1 |
20050222656 | Wahlstrand et al. | Oct 2005 | A1 |
20050222657 | Wahlstrand et al. | Oct 2005 | A1 |
20050222658 | Hoegh et al. | Oct 2005 | A1 |
20050222659 | Olsen et al. | Oct 2005 | A1 |
20050247472 | Helfer et al. | Nov 2005 | A1 |
20050248340 | Berkcan et al. | Nov 2005 | A1 |
20050248907 | Stevenson et al. | Nov 2005 | A1 |
20060009819 | Przybyszewski | Jan 2006 | A1 |
20060025820 | Phillips et al. | Feb 2006 | A1 |
20060028784 | Brendel | Feb 2006 | A1 |
20060030774 | Gray et al. | Feb 2006 | A1 |
20060032665 | Ice | Feb 2006 | A1 |
20060041294 | Gray | Feb 2006 | A1 |
20060085043 | Stevenson | Apr 2006 | A1 |
20060100506 | Halperin et al. | May 2006 | A1 |
20060119361 | Karmarkar et al. | Jun 2006 | A1 |
20060200218 | Wahlstrand | Sep 2006 | A1 |
20060211979 | Smith et al. | Sep 2006 | A1 |
20060212096 | Stevenson | Sep 2006 | A1 |
20060221543 | Stevenson et al. | Oct 2006 | A1 |
20060229693 | Bauer et al. | Oct 2006 | A1 |
20060247684 | Halperin et al. | Nov 2006 | A1 |
20060247747 | Olsen et al. | Nov 2006 | A1 |
20060247748 | Wahlstrand et al. | Nov 2006 | A1 |
20060252314 | Atalar et al. | Nov 2006 | A1 |
20060259093 | Stevenson et al. | Nov 2006 | A1 |
20060271138 | MacDonald | Nov 2006 | A1 |
20070035910 | Stevenson | Feb 2007 | A1 |
20070043399 | Stevenson et al. | Feb 2007 | A1 |
20070083244 | Stevenson et al. | Apr 2007 | A1 |
20070088416 | Atalar et al. | Apr 2007 | A1 |
20070093142 | MacDonald et al. | Apr 2007 | A1 |
20070106332 | Denker et al. | May 2007 | A1 |
20070112398 | Stevenson et al. | May 2007 | A1 |
20070123949 | Dabney et al. | May 2007 | A1 |
20070167867 | Wolf | Jul 2007 | A1 |
20070168005 | Gray | Jul 2007 | A1 |
20070168006 | Gray | Jul 2007 | A1 |
20070179554 | Lyer et al. | Aug 2007 | A1 |
20070179577 | Marshall et al. | Aug 2007 | A1 |
20070203529 | Iyer et al. | Aug 2007 | A1 |
20070208383 | Williams | Sep 2007 | A1 |
20070250143 | Sommer et al. | Oct 2007 | A1 |
20070255332 | Cabelka et al. | Nov 2007 | A1 |
20070255377 | Marshall et al. | Nov 2007 | A1 |
20070288058 | Halperin et al. | Dec 2007 | A1 |
20070299490 | Yang et al. | Dec 2007 | A1 |
20080004670 | McVenes et al. | Jan 2008 | A1 |
20080033497 | Bulkes et al. | Feb 2008 | A1 |
20080039709 | Karmarkar | Feb 2008 | A1 |
20080049376 | Stevenson et al. | Feb 2008 | A1 |
20080049410 | Kawaguchi et al. | Feb 2008 | A1 |
20080051854 | Bulkes et al. | Feb 2008 | A1 |
20080071313 | Stevenson et al. | Mar 2008 | A1 |
20080116997 | Dabney et al. | May 2008 | A1 |
20080132986 | Gray et al. | Jun 2008 | A1 |
20080132987 | Westlund et al. | Jun 2008 | A1 |
20080140149 | John et al. | Jun 2008 | A1 |
20080158746 | Anthony et al. | Jul 2008 | A1 |
20080161886 | Stevenson et al. | Jul 2008 | A1 |
20080195180 | Stevenson et al. | Aug 2008 | A1 |
20080195186 | Li et al. | Aug 2008 | A1 |
20080195187 | Li et al. | Aug 2008 | A1 |
20080221638 | Wedan et al. | Sep 2008 | A1 |
20080239622 | Hsu et al. | Oct 2008 | A1 |
20080243218 | Bottomley et al. | Oct 2008 | A1 |
20080247111 | Anthony et al. | Oct 2008 | A1 |
20080247116 | Kawano et al. | Oct 2008 | A1 |
20080247117 | Elam et al. | Oct 2008 | A1 |
20080262584 | Bottomley et al. | Oct 2008 | A1 |
20080262592 | Jordan et al. | Oct 2008 | A1 |
20080264685 | Park et al. | Oct 2008 | A1 |
20080269591 | Halperin et al. | Oct 2008 | A1 |
20080277153 | Teshome et al. | Nov 2008 | A1 |
20090036944 | Fonte | Feb 2009 | A1 |
20090097219 | Cho et al. | Apr 2009 | A1 |
20090099440 | Mohl | Apr 2009 | A1 |
20090099555 | Viohl et al. | Apr 2009 | A1 |
20090107717 | Hsu et al. | Apr 2009 | A1 |
20090116167 | Stevenson et al. | May 2009 | A1 |
20090128976 | Anthony | May 2009 | A1 |
20090139760 | Tanaka | Jun 2009 | A1 |
20090163974 | Taylor et al. | Jun 2009 | A1 |
20090163980 | Stevenson | Jun 2009 | A1 |
20090180237 | Hou et al. | Jul 2009 | A1 |
20090187229 | Lavie | Jul 2009 | A1 |
20090236141 | Kim et al. | Sep 2009 | A1 |
20090243756 | Stevenson et al. | Oct 2009 | A1 |
20090270948 | Nghiem et al. | Oct 2009 | A1 |
20090281592 | Vase | Nov 2009 | A1 |
20090312835 | Stevenson | Dec 2009 | A1 |
20100010602 | Wedan et al. | Jan 2010 | A1 |
20100016936 | Stevenson et al. | Jan 2010 | A1 |
20100023000 | Stevenson et al. | Jan 2010 | A1 |
20100023095 | Stevenson et al. | Jan 2010 | A1 |
20100046135 | Niki et al. | Feb 2010 | A1 |
20100046137 | Adachi | Feb 2010 | A1 |
20100076538 | Desai et al. | Mar 2010 | A1 |
20100109958 | Haubrich et al. | May 2010 | A1 |
20100109966 | Mateychuk et al. | May 2010 | A1 |
20100114246 | Hill et al. | May 2010 | A1 |
20100114276 | Min et al. | May 2010 | A1 |
20100114277 | Zhao et al. | May 2010 | A1 |
20100138192 | Min | Jun 2010 | A1 |
20100149042 | Utsi et al. | Jun 2010 | A1 |
20100151113 | Shelton | Jun 2010 | A1 |
20100160989 | Legay | Jun 2010 | A1 |
20100174348 | Bulkes et al. | Jul 2010 | A1 |
20100174349 | Stevenson et al. | Jul 2010 | A1 |
20100198312 | Stevenson et al. | Aug 2010 | A1 |
20100217262 | Stevenson et al. | Aug 2010 | A1 |
20100217264 | Odom et al. | Aug 2010 | A1 |
20100217341 | John et al. | Aug 2010 | A1 |
20100234907 | Dobak | Sep 2010 | A1 |
20100241206 | Truex et al. | Sep 2010 | A1 |
20110043297 | Stevenson et al. | Feb 2011 | A1 |
20110248184 | Shah | Oct 2011 | A1 |
20120006576 | Barry et al. | Jan 2012 | A1 |
20120197335 | Reisinger | Aug 2012 | A1 |
20130032378 | Morioka et al. | Feb 2013 | A1 |
20130058003 | Yer et al. | Mar 2013 | A1 |
20130138186 | Yer et al. | May 2013 | A1 |
20130184796 | Marzano et al. | Jul 2013 | A1 |
20140151114 | Morioka et al. | Jun 2014 | A1 |
20140168850 | Stevenson et al. | Jun 2014 | A1 |
20140168917 | Marzano et al. | Jun 2014 | A1 |
20140243944 | Stevenson et al. | Aug 2014 | A1 |
20150004359 | Shahbazi et al. | Jan 2015 | A1 |
20150217111 | Stevenson et al. | Aug 2015 | A1 |
20150245468 | Barry et al. | Aug 2015 | A1 |
20150283374 | Kronmueller et al. | Oct 2015 | A1 |
20150314131 | Marzano et al. | Nov 2015 | A1 |
20150343224 | Woods et al. | Dec 2015 | A1 |
20160151635 | Frysz et al. | Jun 2016 | A1 |
20160263384 | Stevenson et al. | Sep 2016 | A1 |
20160287883 | Barry et al. | Oct 2016 | A1 |
20180126175 | Seitz et al. | May 2018 | A1 |
Number | Date | Country |
---|---|---|
0243573 | Nov 1987 | EP |
0145430 | May 1991 | EP |
0466424 | Jan 1992 | EP |
0557127 | Aug 1993 | EP |
0673621 | Sep 1995 | EP |
0498996 | Mar 1997 | EP |
1021730 | Apr 2003 | EP |
0930509 | Mar 2004 | EP |
1469910 | Dec 2006 | EP |
1883449 | Jan 2009 | EP |
2025361 | Feb 2009 | EP |
2617461 | Jul 2013 | EP |
112617461 | Jul 2013 | EP |
2811900 | Feb 2003 | FR |
60141034 | Jul 1985 | JP |
61181925 | Aug 1986 | JP |
62233905 | Oct 1987 | JP |
4071536 | Mar 1992 | JP |
6054823 | Mar 1994 | JP |
06070902 | Mar 1994 | JP |
6176962 | Jun 1994 | JP |
7272975 | Oct 1995 | JP |
9094238 | Apr 1997 | JP |
11239572 | Sep 1999 | JP |
2004254257 | Sep 2004 | JP |
2004289760 | Oct 2004 | JP |
2005117606 | Apr 2005 | JP |
2007129565 | May 2007 | JP |
3704080 | Jul 1987 | WO |
9210213 | Jun 1992 | WO |
9423782 | Oct 1994 | WO |
9740396 | Oct 1997 | WO |
9852461 | Nov 1998 | WO |
9919739 | Apr 1999 | WO |
0010456 | Mar 2000 | WO |
0025672 | May 2000 | WO |
02083016 | Oct 2002 | WO |
2003037424 | May 2003 | WO |
0003063946 | Aug 2003 | WO |
2003063952 | Aug 2003 | WO |
2003063953 | Aug 2003 | WO |
2003063955 | Aug 2003 | WO |
2003063956 | Aug 2003 | WO |
2003063957 | Aug 2003 | WO |
2005081784 | Sep 2005 | WO |
2005102445 | Nov 2005 | WO |
2005102446 | Nov 2005 | WO |
2005102447 | Nov 2005 | WO |
2005115531 | Dec 2005 | WO |
2006093685 | Sep 2006 | WO |
2007047966 | Apr 2007 | WO |
2007089988 | Aug 2007 | WO |
2007102893 | Sep 2007 | WO |
2007145671 | Dec 2007 | WO |
2008077037 | Jun 2008 | WO |
2008111986 | Sep 2008 | WO |
2010008833 | Jan 2010 | WO |
2013158552 | Oct 2013 | WO |
Entry |
---|
European Search Report, Application No. 10167031.3, dated Sep. 19, 2012. |
Gabriel, et al., “The Dielectric Properties of Biological Tissues; II.”, Measurements in the Frequency Range 10 Hz to 20 GHz, Apr. 2, 1996, 2251-2269. |
Gabriel, et al., “The Dielectric Properlies of Biological Tissues: Parametric Models for the Dielectric Spectrum of Tissues”, Parametric Models for the Dielectric Spectrum of Tissues Phys. Med. Bio. 41, 1996, 2271-2293. |
Johnson, et al., “Characterization of the Relationship between MR-Induced Distal Tip Heating in Cardiac Pacing Leads and Electrical Performance of Novel Filtered Tip Assemblies”, 17th Scientific Meeting & Exhibition of the Intemational Society for Magnetic Resonance in Medicine, Honolulu, Hawaii, Apr. 2009, 307. |
Karbasi, “Developing a High Density PT/Alumina Hermetic Feedthrough”, Florida International University, FIU Digital Commons, FIU Electronic Theses and Dissertations, University Graduate School, Published Jun. 15, 2012. |
Kingery, et al., “Atom Mobility in Introduction to Ceramics, 2nd Edition”, Published in New York, Wiley, copyright 1976, pp. 217-263. |
Kingery, et al., “Surfaces, Interfaces, and Grain Boundaries in Introduction to Ceramics”, 2nd Edition, Publiched in New York, Wiley, copyright 1976, pp. 177-215. |
Konings, et al., “Heating Around Intravascular Guidewires by Resonating RF Waves”, Journal of Magnetic Resonance Imaging, 2000, 79-85. |
Lamouri, et al., “Control of the y-alumina to a-alumina phase transformation for an optimized alumina densification”, Boletin de la Sociedad Espanola De Ceramica Y Vidrio 56 (2017) pp. 47-54. |
Luchinger, “Safety Aspects of Cardiac Pacemakers in Magnetic Resonance Imaging”, A dissertation submitted to the Swiss Federal Institute of Technology Zurich, Switzerland, 2002. |
Plenick, “Ultrathin Flexible Ceramics for Electronics Applications”, www.ceramicindustry.com—Product Profile, Oct. 2016, pp. 30 and 31. |
Roguin, et al., “Modern Pacemaker and Implantable Cardioverter/Defibrillator systems Can Be Magnetic Resonance Imaging Safe”, Journal of the American Heart Association, Aug. 4, 2004, 475-482. |
Sakabe, et al., “High Frequency Performance of Multilayer Ceramic Capacitors”, Electronic Components and Technology Confrerence, 1995, Proceedings 45th, May 21, 1995, 234-240. |
Sarda, et al., “Ceramic EMI Filters—A Review”, American Ceramic Society Bulletin; vol. 67, No. 4, 1988, 737-746. |
Shellock, et al., “Comparative Analyses of MR-Induced Distal Heating in Novel Filtered Cardiac Pacing Leads UsingTwo Geometric Configurations”, 17th Scientific Meeting & Exhibition of the Intemational Society for Magnetic Resonance in Medicine, Honolulu, Hawaii, Apr. 2009, 3014. |
Shellock, “MRI Issues for Neuromodulation Devices”, Institute for Magnetic Resonance Safety Education, and Research (Imrser). |
Susil, et al., “Multifunctional Interventional Devices for MRI: A Combined Electrophysiology/MRI Catheter”, 2002, 694-600. |
Susil, et al., “U.S. Appl. No. 60/283,725”, Multifunctional Interventional Devices for Use in MRI, Apr. 13, 2001. |
Weiner, et al., “U.S. Appl. No. 60/269,817”, Electromagnetic Interference immune Cardiac Assist System, Feb. 20, 2001. |
Wilk, et al., “High-K Gate Dielectrics: Current Status and Materials Properties Considerations”, Journal of Applied Physi s, vol. 89, No. 10, May 15, 2001, 5243-5275. |
European Search Report, Application No. 15165863.0, dated Sep. 12, 2016. |
European Search Report, Application No. 18150642.9, dated Jun. 6, 2018. |
European Search Report, Application No. 12157697.9, dated Jul. 5, 2012. |
Extended European Search Report, Application 17201160.3, dated Apr. 16, 2018. |
Extended European Search Report, Application No. 17197151.8, dated Apr. 26, 2018. |
Extended European Search Report, Application No. 16175505.3, dated Nov. 15, 2016. |
Extended European Search Report, Application No. 18177098.3, dated Aug. 8, 2018. |
“Holy Stone Enterprise”, Ceramic Capacitor Catalog 2008-2009, May 2008. |
“Wikipedia article”, EIA Class 1 dielectric., Sep. 13, 2006. |
Balanis, “Advanced Engineering Electromagnetics”, 1989. |
Becker, “Die Keimbildung Bei Der Ausscheidung in Metallischen Mischkristallen”, Published in Annalen der Physik, Issue 5, vol. 32, 1938, pp. 128-140. |
Boser, et al., “High Frequency Behavior of Ceramic Multilayer Capacitors”, IEEE Transactions on Components, Hybrids, and Manufacturing Technology, vol. CHMT-10, No. 3, Sep. 1987, 437-439. |
Clement, et al., “Estimation of Effective Lead Loop Area for Implantable Pulse Generators and Cardioverter/ Defibrillators for Determination of Susceptibility to Radiated Electromagnetic Interference”, AAMI EMC Task Force, Apr. 12, 2004, 10 pages. |
Ennis, et al., “Cautions About the Use of Equivalent Series Resistance (ESR) in Specifying Capacitors”, Mar. 8, 1993, 68-64. |
Number | Date | Country | |
---|---|---|---|
20210154483 A1 | May 2021 | US |
Number | Date | Country | |
---|---|---|---|
62646522 | Mar 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16362043 | Mar 2019 | US |
Child | 17165500 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16121716 | Sep 2018 | US |
Child | 16362043 | US | |
Parent | 15943998 | Apr 2018 | US |
Child | 16121716 | US |